Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta
- 30 November 2004
- journal article
- clinical trial
- Published by Elsevier BV in Bone
- Vol. 35 (5), 1038-1045
- https://doi.org/10.1016/j.bone.2004.07.003
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Intravenous Bisphosphonate Therapy in Children With Osteogenesis ImperfectaPEDIATRICS, 2003
- Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfectaArchives of Disease in Childhood, 2002
- Cyclic Administration of Pamidronate in Children with Severe Osteogenesis ImperfectaNew England Journal of Medicine, 1998
- Intravenous pamidronate treatment in osteogenesis imperfectaThe Journal of Pediatrics, 1997
- Treatment of osteogenesis imperfecta with the bisphosphonate olpadronate (dimethylaminohydroxypropylidene bisphosphonate)European Journal of Pediatrics, 1997
- Long-Term Effects of Bisphosphonates on the Growing Skeleton: Studies of Young Patients with Severe OsteoporosisMedicine, 1997
- Osteogenesis imperfecta and other heritable disorders of boneBailliere's Clinical Endocrinology and Metabolism, 1997
- Is APD a Promising Drug in the Treatment of Severe Osteogenesis Imperfecta?Journal of Pediatric Orthopaedics, 1988
- Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfectaSkeletal Radiology, 1987
- Genetic heterogeneity in osteogenesis imperfecta.Journal of Medical Genetics, 1979